Association of polymorphisms of the and genes with bone mineral density in postmenopausal women from western Mexico.
作者信息
González-Mercado Anahi, Sánchez-López Josefina Y, Perea-Díaz Francisco J, Magaña-Torres Maria T, Salazar-Páramo Mario, González-López Laura, González-Mercado Mirna Gisel, Ibarra-Cortés Bertha
机构信息
Doctorado en Genética Humana, CUCS, UdeG. Guadalajara, Jalisco, México.
División de Genética, CIBO, IMSS, Guadalajara, Jalisco, México.
出版信息
Arch Med Sci. 2019 Sep;15(5):1352-1356. doi: 10.5114/aoms.2019.87410. Epub 2019 Aug 22.
Abstract
摘要
相似文献
1
Association of polymorphisms of the and genes with bone mineral density in postmenopausal women from western Mexico.
Arch Med Sci. 2019 Sep;15(5):1352-1356. doi: 10.5114/aoms.2019.87410. Epub 2019 Aug 22.
2
TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women.
Maturitas. 2012 Jan;71(1):49-54. doi: 10.1016/j.maturitas.2011.10.009. Epub 2011 Nov 10.
3
TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Maturitas. 2011 Jul;69(3):263-7. doi: 10.1016/j.maturitas.2011.02.010. Epub 2011 Mar 15.
4
Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
Maturitas. 2006 Oct 20;55(3):219-26. doi: 10.1016/j.maturitas.2006.03.004. Epub 2006 May 26.
5
Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women.
Am J Hum Biol. 2013 Nov-Dec;25(6):713-8. doi: 10.1002/ajhb.22464. Epub 2013 Oct 15.
6
Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
J Mol Endocrinol. 2008 Jun;40(6):273-9. doi: 10.1677/JME-08-0003.
7
The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
J Mol Endocrinol. 2009 Mar;42(3):239-47. doi: 10.1677/JME-08-0108. Epub 2009 Jan 8.
8
TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
Maturitas. 2006 Mar 20;53(4):386-95. doi: 10.1016/j.maturitas.2005.11.003. Epub 2005 Dec 15.
9
Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
Drug Metabol Drug Interact. 2014;29(2):111-4. doi: 10.1515/dmdi-2013-0066.
10
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure.
Osteoporos Int. 2018 Feb;29(2):339-346. doi: 10.1007/s00198-017-4272-0. Epub 2017 Oct 16.
引用本文的文献
1
Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women.
Biomedicines. 2023 Dec 4;11(12):3218. doi: 10.3390/biomedicines11123218.
2
Association between polymorphisms and osteoporosis risk: An updated meta-analysis.
Front Genet. 2022 Nov 9;13:1032110. doi: 10.3389/fgene.2022.1032110. eCollection 2022.
3
Association of Genetic Polymorphisms in with the Progression of Genetic Susceptibility to Gastric Cancer.
J Oncol. 2020 Jun 22;2020:4103264. doi: 10.1155/2020/4103264. eCollection 2020.
本文引用的文献
1
Evaluation of the quality of life of postmenopausal osteoporotic and osteopenic women with or without fractures.
Arch Med Sci. 2016 Aug 1;12(4):819-27. doi: 10.5114/aoms.2015.55012. Epub 2015 Nov 4.
2
Guidelines for the diagnosis, prevention and management of osteoporosis.
Reumatismo. 2016 Jun 23;68(1):1-39. doi: 10.4081/reumatismo.2016.870.
3
Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients.
Genet Test Mol Biomarkers. 2016 May;20(5):249-54. doi: 10.1089/gtmb.2015.0227. Epub 2016 Feb 25.
4
Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report.
J Immunol Res. 2015;2015:376197. doi: 10.1155/2015/376197. Epub 2015 May 3.
5
Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
Osteoporos Int. 2015 Jan;26(1):179-85. doi: 10.1007/s00198-014-2854-7. Epub 2014 Aug 20.
6
[Risk factors for osteoporosis in postmenopausal women from Guadalajara, Jalisco].
Salud Publica Mex. 2013 Dec;55(6):627-30.
7
Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women.
Am J Hum Biol. 2013 Nov-Dec;25(6):713-8. doi: 10.1002/ajhb.22464. Epub 2013 Oct 15.
8
Bone mineral density in postmenopausal Mexican-Mestizo women with normal body mass index, overweight, or obesity.
Menopause. 2013 May;20(5):568-72. doi: 10.1097/GME.0b013e318277694f.
9
Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
Clin Biochem. 2013 Oct;46(15):1493-501. doi: 10.1016/j.clinbiochem.2013.03.011. Epub 2013 Mar 24.
10
Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women.
J Bone Miner Res. 2012 Dec;27(12):2582-91. doi: 10.1002/jbmr.1711.
Zotero 插件